Literature DB >> 31813308

Acute hemichorea in a young type 1 diabetic.

Jeremy B Lin1, Andrew A Sng1, Furene S Wang1, Ai Peng Tan2, Velda X Han1.   

Abstract

Purpose/Aim: Acute movement disorder is an uncommon presenting symptom in patients with diabetes mellitus. We report a 20-year-old lady with poorly controlled type 1 diabetes, who presented with acute hemichorea and was found to have two rare diabetes-related central nervous complications of diabetic striatopathy and severe moyamoya disease (MMD).Materials and methods: She was treated with aggressive glycemic control; clonazepam and tetrabenazine as well as aspirin stroke prophylaxis for her MMD with resolution of her chorea 3 months later. She subsequently underwent cerebral revascularization surgery for her MMD.
Results: This case highlights the possible differentials of acute chorea in diabetic patients and explores the pathophysiological mechanisms that may underlie both conditions in patients with type 1 diabetes.
Conclusion: We recommend performing both magnetic resonance imaging (MRI) and magnetic resonance angiogram (MRA) brain for comprehensive evaluation of diabetic patients with new onset chorea. Prompt and accurate diagnosis is crucial as it guides prognostication and treatment strategies.

Entities:  

Keywords:  Diabetic striatopathy; chorea; movement disorder; moyamoya disease

Mesh:

Year:  2019        PMID: 31813308     DOI: 10.1080/00207454.2019.1702540

Source DB:  PubMed          Journal:  Int J Neurosci        ISSN: 0020-7454            Impact factor:   2.292


  2 in total

1.  Is diabetic striatopathy the culprit of seizures in a patient with ketotic hyperglycemia-induced hemichorea-hemiballismus?

Authors:  Abeer Sabry Safan; Omna Sharma; Muna Almasri; Ashton Ian D'Souza; Omer Suliman
Journal:  BMC Neurol       Date:  2022-04-08       Impact factor: 2.474

Review 2.  Clinical and imaging features of diabetic striatopathy: report of 6 cases and literature review.

Authors:  Yun Yue; Chengxin Yan; Yuanyuan Xu; Qiang Shi
Journal:  Neurol Sci       Date:  2022-08-15       Impact factor: 3.830

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.